Ascentage Pharma Group International (HKG:6855)

HKG:6855 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,710	14,071	7,772	6,636	7,264	8,500
Market Cap Growth	157.91%	81.06%	17.11%	-8.65%	-14.53%	39.14%
Enterprise Value	26,781	14,727	7,885	6,475	6,225	8,105
Last Close Price	72.70	45.45	27.30	25.70	28.20	38.50
PS Ratio	62.40	13.48	31.78	27.99	212.05	574.86
PB Ratio	36.06	48.23	99.87	14.36	4.79	8.45
P/TBV Ratio	42.74	80.87	-	19.59	5.15	9.47
EV/Sales Ratio	62.57	14.11	32.24	27.31	181.70	548.17
Debt / Equity Ratio	2.54	6.09	25.42	4.39	0.88	0.63
Asset Turnover	0.13	0.38	0.08	0.07	0.01	0.01
Inventory Turnover	3.70	2.56	2.38	3.29	-	-
Quick Ratio	1.40	1.17	1.35	1.78	5.05	3.77
Current Ratio	1.54	1.26	1.44	1.86	5.22	3.91
Return on Equity (ROE)	-159.65%	-235.32%	-386.28%	-107.45%	-75.18%	-78.02%
Return on Assets (ROA)	-22.77%	-9.25%	-20.92%	-19.14%	-24.97%	-29.14%
Return on Capital (ROIC)	-28.78%	-12.43%	-27.41%	-24.43%	-31.57%	-36.13%
Earnings Yield	-4.76%	-3.07%	-13.12%	-15.04%	-13.22%	-9.47%
FCF Yield	-0.89%	-1.03%	-10.95%	-14.60%	-17.57%	-12.02%
Buyback Yield / Dilution	-12.40%	-7.00%	-7.07%	-3.56%	-17.93%	-84.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.